Pharmidex's 2024 wrapped
January 10, 2025

Pharmidex is pleased to announce that Ash Alavijeh , will be attending Bio Integrates 2026 on 14 May 2026 at Victoria House, Bloomsbury, London. Ash looks forward to meeting founders, investors, biotech leaders and scientific partners to discuss drug discovery, translational development and new opportunities across the life sciences sector. He will be delighted to connect with attendees and explore new collaborations and partnerships in the drug development field, feel free to catch him for a chat!

We are delighted to welcome Yvonne Squire to the Pharmidex team as our new Senior Histologist. Yvonne brings over 15 years of experience in non-clinical histology and toxicology, with expertise in necropsy, tissue preparation, histochemical techniques and GLP-compliant laboratory operations. Her experience will further strengthen Pharmidex’s histology and translational research capabilities. Welcome to Pharmidex, Yvonne!

We are delighted to announce and congratulate Ash Alavijeh on his appointment as Chief Operating Officer at Pharmidex . Ash has been an integral part of Pharmidex’s journey, bringing strong leadership, strategic vision and a deep commitment to advancing our capabilities in drug discovery and development. In his new role as COO, he will play a key part in driving operational excellence and supporting the continued growth of the company. This appointment reflects both Ash’s contributions to date and our confidence in his leadership as we continue to expand and evolve. Please join us in congratulating Ash on this well-deserved achievement.





